Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Objectives To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC). Methods The ECV fraction before NCRT (ECV pre) and/or...
Gespeichert in:
Veröffentlicht in: | European radiology 2023-06, Vol.33 (6), p.4042-4051 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objectives
To determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC).
Methods
The ECV fraction before NCRT (ECV
pre)
and/or ECV after NCRT (ECV
post
) of rectal tumors was assessed, and ECV
Δ
was calculated as ECV
post
− ECV
pre
. The histopathologic tumor regression grading (TRG) was assessed. pCR (TRG 0 grade) was defined as the absence of viable tumor cells in the primary tumor and lymph nodes. Demographic and clinicopathological characteristics and ECV fraction were compared between the pCR and non-pCR groups. A mixed model was constructed by logistic regression. The performance for predicting pCR was assessed with the area under the receiver-operator curve (AUC). The AUCs of the different methods were compared by the method proposed by DeLong et al.
Results
Seventy-five patients were included; 17 achieved pCR, and 58 achieved non-pCR. The ECV
post
(17.05 ± 2.36% vs. 29.94 ± 1.20%;
p
< 0.001) and ECV
Δ
(− 17.01 ± 3.01% vs. 0.44 ± 1.45%;
p
< 0.001) values in the pCR group were significantly lower than those in the non-pCR group. The mixed model that combined ECV
post
with ECV
Δ
achieved an AUC of 0.92 (95% confidence interval (CI) = 0.81–0.98), which was higher than that of ECV
post
(AUC, 0.91 (95% CI = 0.80–0.97);
p
= 0.60) or ECV
Δ
(AUC, 0.90 (95% CI = 0.79–0.97);
p
= 0.61).
Conclusions
ECV
post
and ECV
Δ
determined by using equilibrium contrast-enhanced CT were useful in distinguishing between pCR and non-pCR patients with LARC who received NCRT.
Key Points
• ECV
post
and ECV
Δ
(ECV
post
− ECV
pre
) differed significantly between the non-pCR and pCR groups.
• ECV
pre
cannot be used to predict the efficacy of neoadjuvant chemoradiotherapy.
• ECV
post
combined with ECV
Δ
had the best performance with an AUC of 0.92 for predicting pCR after NCRT in LARC. |
---|---|
ISSN: | 1432-1084 0938-7994 1432-1084 |
DOI: | 10.1007/s00330-022-09307-z |